| Index | — | P/E | — | EPS (ttm) | -0.87 | Insider Own | 46.77% | Shs Outstand | 49.15M | Perf Week | -8.18% |
| Market Cap | 877.37M | Forward P/E | 143.62 | EPS next Y | 0.12 | Insider Trans | -11.19% | Shs Float | 39.64M | Perf Month | -27.62% |
| Enterprise Value | 762.37M | PEG | — | EPS next Q | -0.04 | Short Float | 7.01% | Perf Quarter | -44.38% | ||
| Income | -40.00M | P/S | 10.44 | EPS this Y | — | Short Ratio | 4.10 | Perf Half Y | -38.13% | ||
| Sales | 84.00M | P/B | 12.90 | EPS next Y | — | ROA | -17.59% | Short Interest | 2.78M | Perf YTD | 15.16% |
| Book/sh | 1.38 | P/C | 7.19 | EPS next 5Y | — | ROE | -357.77% | 52W High | 50.26 -64.48% | Perf Year | 34.11% |
| Cash/sh | 2.48 | P/FCF | 125.34 | EPS past 3/5Y | — | ROIC | -27.82% | 52W Low | 12.06 48.01% | Perf 3Y | 235.53% |
| Dividend Est. | — | EV/EBITDA | — | Sales past 3/5Y | 12.40% 17.28% | Gross Margin | 86.85% | Volatility | 6.15% 5.46% | Perf 5Y | — |
| Dividend TTM | — | EV/Sales | 9.08 | EPS Y/Y TTM | — | Oper. Margin | -47.04% | ATR (14) | 1.38 | Perf 10Y | — |
| Dividend Ex-Date | — | Quick Ratio | 1.57 | Sales Y/Y TTM | 31.25% | Profit Margin | -46.70% | RSI (14) | 35.60 | Recom | 2.14 |
| Dividend Gr. 3/5Y | — | Current Ratio | 1.57 | EPS Q/Q | 9.09% | SMA20 | -13.09% | Beta | 3.68 | Target Price | 39.60 |
| Payout | 0.00% | Debt/Eq | 0.10 | Sales Q/Q | 41.18% | SMA50 | -18.23% | Rel Volume | 1.10 | Prev Close | 18.80 |
| Employees | 364 | LT Debt/Eq | 0.09 | Earnings | Nov 05 | SMA200 | -28.75% | Avg Volume | 669.09K | Price | 17.85 |
| IPO Date | Oct 27, 2021 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -140.58% 2.78% | Net Debt/EBITDA | — | Volume | 734,975 | Change | -5.05% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Sep-21-26 | Initiated | Craig-Hallum | Buy | $30 |
| Aug-07-26 | Upgrade | Jefferies | Hold → Buy | $35 → $50 |
| Aug-04-26 | Initiated | Roth Capital | Buy | $40 |
| Jul-16-26 | Initiated | Oppenheimer | $40 | |
| May-13-26 | Reiterated | Northland Securities | Outperform | $24 → $38 |
| May-13-26 | Reiterated | Jefferies | Hold | $35 |
| Feb-13-26 | Reiterated | Northland Securities | Outperform | $21 → $24 |
| Nov-05-25 | Reiterated | Rosenblatt | Buy | $20 |
| May-29-24 | Reiterated | Northland Securities | Outperform | $14 |
| May-13-24 | Downgrade | Jefferies | Buy → Hold |
Arteris, Inc., together with its subsidiaries, provides semiconductor system intellectual property (IP) solutions in the United States, rest of the Americas, China, Korea, the rest of the Asia Pacific, Europe, and the Middle East. It manages on-chip communications and IP block deployments in System-on-Chip (SoC) semiconductors and systems of chiplets. The company offers Network-on-Chip (NoC) IP Products, such as FlexGen, FlexNoC, and FlexWay, a non-coherent NoC IP; Ncore, a cache-coherent NoC IP; and CodaCache, a last-level cache. It also provides hardware security verification software products, such as Cycuity Radix-S to detect and remediate security issues in IP blocks and subsystems of an SoC; Cycuity Radix-M for hardware security verification emulation for system-level SoC and firmware; and Cycuity Radix-ST, a static security analyzer that identifies potential design weaknesses early in the development lifecycle, as well as SoC integration automation software solutions products, including Magillem Connectivity and Registers, and CSRCompiler. In addition, the company offers professional services, such as training, design assistance, and consulting; licensing services for software and intellectual properties; IP support and maintenance; and on-site support services. It serves the automotive, communications, enterprise computing, consumer electronics, and industrial markets. Arteris, Inc. was founded in 2003 and is headquartered in Campbell, California.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 84 | 71 | 58 | 54 | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 12 | 7 | 6 | 5 | — | — | — | — | |
| Gross Profit | 74 | 64 | 52 | 49 | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 55 | 47 | 38 | 39 | — | — | — | — | |
| Research and Development | 57 | 50 | 45 | 45 | — | — | — | — | |
| Other Operating Expense | 1 | 0 | 0 | 0 | — | — | — | — | |
| Operating Income | -40 | -33 | -32 | -35 | — | — | — | — | |
| Interest Expense | 0 | 0 | 0 | 0 | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -2 | 0 | 1 | 0 | — | — | — | — | |
| Net Income Before Taxes | -43 | -33 | -31 | -35 | — | — | — | — | |
| Income Taxes | -3 | 1 | 3 | 2 | — | — | — | — | |
| Consolidated Net Income | -40 | -35 | -34 | -37 | — | — | — | — | |
| Net Income From Continuing Operations | -40 | -35 | -34 | -37 | — | — | — | — | |
| Net Income | -40 | -35 | -34 | -37 | — | — | — | — | |
| EPS (Recurring) | -0.87 | -0.82 | -0.86 | -1.03 | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | -0.87 | -0.82 | -0.86 | -1.03 | — | — | — | — | |
| EPS (Diluted) | -0.87 | -0.82 | -0.86 | -1.03 | — | — | — | — | |
| EBITDA | -38 | -30 | -25 | -29 | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | — | — | — | — | — | — | — | — | |
| Price To Sales Ratio | 9.99 | 9.17 | 6.85 | 3.93 | — | — | — | — | |
| Gross Margin | 88.10 | 90.14 | 89.66 | 90.74 | — | — | — | — | |
| Operating Margin | -47.62 | -46.48 | -55.17 | -64.81 | — | — | — | — | |
| Net Margin | -47.62 | -49.30 | -58.62 | -68.52 | — | — | — | — | |
| Shares Outstanding | 47 | 42 | 39 | 36 | — | — | — | — | |
| Market Capitalization | 839 | 651 | 397 | 212 | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Alpern Paul L | VP and General Counsel | Oct 05 '26 | Sale | 24.24 | 6,003 | 145,500 | 61,082 | Oct 06 |
| JANAC K CHARLES | President and CEO | Oct 05 '26 | Sale | 24.27 | 11,452 | 277,987 | 154,337 | Oct 06 |
| Moll Laurent R | Chief Operating Officer | Oct 05 '26 | Sale | 24.29 | 12,219 | 296,775 | 194,659 | Oct 06 |
| Moll Laurent R | Chief Operating Officer | Oct 02 '26 | Sale | 24.64 | 5,600 | 138,001 | 206,878 | Oct 06 |
| JANAC K CHARLES | President and CEO | Oct 02 '26 | Sale | 24.64 | 9,359 | 230,635 | 165,789 | Oct 05 |
| Alpern Paul L | VP and General Counsel | Oct 02 '26 | Sale | 24.64 | 3,648 | 89,899 | 67,085 | Oct 05 |
| Bayview Legacy, LLC | 10% Owner | Oct 01 '26 | Sale | 23.82 | 100,000 | 2,382,390 | 8,129,071 | Oct 05 |
| Alpern Paul L | VP and General Counsel | Oct 01 '26 | Option Exercise | 3.91 | 6,500 | 25,440 | 77,233 | Oct 05 |
| Alpern Paul L | VP and General Counsel | Oct 01 '26 | Sale | 23.84 | 6,500 | 154,933 | 70,733 | Oct 05 |
| JANAC K CHARLES | President and CEO | Oct 01 '26 | Sale | 23.82 | 100,000 | 2,382,390 | 8,129,071 | Oct 05 |
| Moll Laurent R | Chief Operating Officer | Sep 14 '26 | Sale | 20.85 | 9,219 | 192,223 | 212,478 | Sep 15 |
| JANAC K CHARLES | President and CEO | Sep 01 '26 | Sale | 20.75 | 100,000 | 2,074,970 | 8,229,071 | Sep 03 |
| Bayview Legacy, LLC | 10% Owner | Sep 01 '26 | Sale | 20.75 | 100,000 | 2,074,970 | 8,229,071 | Sep 03 |
| Alpern Paul L | VP and General Counsel | Sep 01 '26 | Option Exercise | 0.56 | 4,000 | 2,240 | 74,733 | Sep 03 |
| Alpern Paul L | VP and General Counsel | Sep 01 '26 | Sale | 20.77 | 4,000 | 83,063 | 70,733 | Sep 03 |